Sephardic origins revealed for rare skin disorder, recessive dystrophic epidermolysis bullosa, in individuals carrying the unique c.6527insC mutation

The identification of this unique RDEB subpopulation unified by the single most prevalent c.6527insC mutation holds great potential to facilitate promising new RDEB therapies using CRISPR Cas 9 gene and base editing. The identification of a single guide RNA allowing efficient and safe editing of this variant would represent a unique drug to treat a large cohort of patients with the same founder mutation.

Authors

Institutions

Publication Details

Journal
Journal of Medical Genetics
Published
2025-09-24
DOI
https://doi.org/10.1136/jmg-2025-110967
Primary Topic
Skin and Cellular Biology Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sephardic origins revealed for rare skin disorder, recessive dystrophic epidermolysis bullosa, in individuals carrying the unique c.6527insC mutation

Francis Palisson, Paul Maier, Ganna Bilousova, Nuria Illera et al.
Journal of Medical Genetics
Skin and Cellular Biology Research
article

Sephardic origins revealed for rare skin disorder, recessive dystrophic epidermolysis bullosa, in individuals carrying the unique c.6527insC mutation

Francis Palisson, Paul Maier, Ganna Bilousova, Nuria Illera, Adam R. Brown, Graciela Manzur, Marcela Del Río, Fernando Larcher, Anthony E. Oro, Jean Y. Tang, Anna L. Bruckner, Ignacia Fuentes, Igor Kogut, Matthias Titeux, Liliana Consuegra, Almudena Holguín, Emily Warshauer, Maria Jose Escamez, Laura Valinotto, Mónica Natale, Garrett Hellenthal, Dennis R. Roop, A. Hovnanian, Göran Runfeldt, Ángeles Mencía, Inês Nogueiro, Karl Skorecki, Marta García, David A. Norris, Carolina Rivera, Eli Sprecher, Peter Marinkovich
article en

Abstract

The identification of this unique RDEB subpopulation unified by the single most prevalent c.6527insC mutation holds great potential to facilitate promising new RDEB therapies using CRISPR Cas 9 gene and base editing. The identification of a single guide RNA allowing efficient and safe editing of this variant would represent a unique drug to treat a large cohort of patients with the same founder mutation.

Journal of Medical GeneticsVol. 63(1)
Universidad del Desarrollo (CL), Inserm (FR), Pontificia Universidad Católica de Chile (CL), Tel Aviv University (IL), Technion – Israel Institute of Technology (IL), Universidade do Porto (PT), Université Paris Cité (FR), Fundación Chile (CL), Tel Aviv Sourasky Medical Center (IL), Hospital for Sick Children Pediatric Center (US), Gene Therapy Laboratory (FR), Centro Científico Tecnológico - San Juan (AR), Fundación Cardiovascular de Colombia (CO), Assistance Publique – Hôpitaux de Paris (FR), Rappaport Family Institute for Research in the Medical Sciences (IL), Unidades Centrales Científico-Técnicas (ES), Hospital de Clínicas "José de San Martín" (AR), Fundación Neumológica Colombiana (CO), Fundación Santa Fe de Bogotá (CO), Center for the Study of State and Society (AR), Institute of Genetics and Cancer (GB), Instituto de Investigación de Enfermedades Raras (ES), Human Genetic of Infectious Diseases (FR), Institut des Maladies Génétiques Imagine (FR), Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (ES), Adult and Pediatric Dermatology (US), University College London (GB), Universidad Carlos III de Madrid (ES), University of Colorado Anschutz Medical Campus (US), Howard Payne University (US), Universidad del Rosario (CO), Stanford University (US)
Openalex Percentile: Top 72%
Skin and Cellular Biology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.